Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Corneal defect | Phase 1 | US | 24 Jan 2024 | |
Corneal epithelial defect | Phase 1 | US | 24 Jan 2024 |